Safety/ Feasibility of Percutaneous Administration of Vonapanitase as Monotherapy for Peripheral Artery Disease (PAD) of the SFA and Popliteal Arteries

Summary

The research study is designed to assess the technical feasibility and safety of percutaneous administration of vonapanitase to the superficial femoral or popliteal artery in patients with PAD.

Timeline

Start

—

Primary completion

2019-04-30

Completion

2019-04-30

Outcome

Outcome not reported

Stopped: “Change in operating plans”

Drugs

Indications